{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:03:23Z","timestamp":1772845403428,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s40261-017-0542-z","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T05:00:34Z","timestamp":1497243634000},"page":"853-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial"],"prefix":"10.1007","volume":"37","author":[{"given":"Zahra","family":"Ghelich Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita Hajhossein","family":"Talasaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Pourhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kianoush","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Alemzadeh Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"issue":"10","key":"542_CR1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/hrt.2009.186189","volume":"96","author":"F Cuculi","year":"2010","unstructured":"Cuculi F, Lim CCS, Banning P. Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented? Heart. 2010;96(10):736\u201340.","journal-title":"Heart"},{"issue":"3","key":"542_CR2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/1995-705X.125926","volume":"14","author":"NM Mohammed","year":"2013","unstructured":"Mohammed NM, Mahfouz A, Achkar K, et al. Contrast-induced nephropathy. Heart Views. 2013;14(3):106\u201316.","journal-title":"Heart Views"},{"key":"542_CR3","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ki.5000368","volume":"100","author":"R Mehran","year":"2006","unstructured":"Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:S11\u20135.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"542_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carj.2012.11.002","volume":"65","author":"RJ Owen","year":"2014","unstructured":"Owen RJ, Hiremath S, Myers A, et al. Canadian Association of Radiologists Consensus Guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65(2):96\u2013105.","journal-title":"Can Assoc Radiol J"},{"issue":"10","key":"542_CR5","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","volume":"18","author":"FJ Hoek","year":"2003","unstructured":"Hoek FJ, Kemperman FW, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024\u201331.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"542_CR6","first-page":"CR440","volume":"16","author":"P Przybylowski","year":"2010","unstructured":"Przybylowski P, Malyszko J, Malyszko J. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients. Med Sci Monit. 2010;16(9):CR440\u20134.","journal-title":"Med Sci Monit"},{"key":"542_CR7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.ccx.0000145095.90327.f2","volume":"10","author":"WK Han","year":"2004","unstructured":"Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care. 2004;10:476\u201382.","journal-title":"Curr Opin Crit Care."},{"issue":"January","key":"542_CR8","first-page":"w13744","volume":"143","author":"S Seitz","year":"2013","unstructured":"Seitz S, Rauh M, Gloeckler M, et al. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery. Swiss Med Wkly. 2013;143(January):w13744.","journal-title":"Swiss Med Wkly."},{"issue":"2","key":"542_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP61098","volume":"61","author":"H Rickli","year":"2004","unstructured":"Rickli H, Benou K, Ammann P, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004;61(2):98\u2013102.","journal-title":"Clin Nephrol"},{"issue":"19","key":"542_CR10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/CIRCULATIONAHA.109.919639","volume":"121","author":"C Briguori","year":"2010","unstructured":"Briguori C, Visconti G, Rivera NV, et al. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010;121(19):2117\u201322.","journal-title":"Circulation"},{"issue":"3","key":"542_CR11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","volume":"66","author":"S Herget-Rosenthal","year":"2004","unstructured":"Herget-Rosenthal S, Marggraf G, H\u00fcsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66(3):1115\u201322.","journal-title":"Kidney Int"},{"issue":"4","key":"542_CR12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0030-1267860","volume":"27","author":"RK Gupta","year":"2010","unstructured":"Gupta RK, Bang TJ. Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice. Semin Interv Radiol. 2010;27(4):348\u201359.","journal-title":"Semin Interv Radiol."},{"issue":"4","key":"542_CR13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ijcard.2012.04.068","volume":"167","author":"T Erol","year":"2013","unstructured":"Erol T, Tekin A, Kat\u0131rc\u0131ba\u015f\u0131 MT, et al. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. Int J Cardiol. 2013;167(4):1396\u20139.","journal-title":"Int J Cardiol"},{"key":"542_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","volume":"68","author":"PB Persson","year":"2005","unstructured":"Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium\u2014induced nephropathy. Kidney Int. 2005;68:14\u201322.","journal-title":"Kidney Int"},{"issue":"1","key":"542_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-86-1-56","volume":"86","author":"LA Weinrauch","year":"1977","unstructured":"Weinrauch LA, Healy RW, Leland OS, et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med. 1977;86(1):56\u20139.","journal-title":"Ann Intern Med"},{"issue":"6","key":"542_CR16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000542-200106000-00030","volume":"94","author":"CD Collard","year":"2001","unstructured":"Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia\u2013reperfusion injury. Anesthesiology. 2001;94(6):1133\u20138.","journal-title":"Anesthesiology"},{"issue":"26","key":"542_CR17","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","volume":"354","author":"G Marenzi","year":"2006","unstructured":"Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast induced nephropathy in primary angioplasty. N Engl J Med. 2006;354(26):2773\u201382.","journal-title":"N Engl J Med"},{"issue":"3","key":"542_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/AJR.07.2356","volume":"189","author":"PA Poletti","year":"2007","unstructured":"Poletti PA, Saudan P, Platon A, et al. Iv N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. Am J Roentgenol. 2007;189(3):687\u201392.","journal-title":"Am J Roentgenol."},{"key":"542_CR19","unstructured":"ACR Committee on Drugs and Contrast Media, ACR Manual on Contrast Media, Version 10.2. American College of Radiology. 2016."},{"issue":"1","key":"542_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"M Leoncini","year":"2014","unstructured":"Leoncini M, Toso A, Maioli M, et al. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome). J Am Coll Cardiol. 2014;63(1):71\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"542_CR21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40265-014-0233-5","volume":"74","author":"P Chrusciel","year":"2014","unstructured":"Chrusciel P, Rysz J, Banach M. Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease. Drugs. 2014;74(9):971\u201380.","journal-title":"Drugs."},{"issue":"5","key":"542_CR22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MAJ.0000000000000575","volume":"350","author":"W Liu","year":"2015","unstructured":"Liu W, Ming Q, Shen J, et al. Trimetazidine prevention of contrast-induced nephropathy in coronary angiography. Am J Med Sci. 2015;350(5):398\u2013402.","journal-title":"Am J Med Sci"},{"issue":"6","key":"542_CR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1074248415573320","volume":"20","author":"GN Nadkarni","year":"2015","unstructured":"Nadkarni GN, Konstantinidis I, Patel A, et al. Trimetazidine decreases risk of contrast-induced nephropathy in patients with chronic kidney disease a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2015;20(6):539\u201346.","journal-title":"J Cardiovasc Pharmacol Ther."},{"issue":"2","key":"542_CR24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijcard.2007.04.048","volume":"127","author":"H Bachorzewska-Gajewska","year":"2008","unstructured":"Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Int J Cardiol. 2008;127(2):290\u20131.","journal-title":"Int J Cardiol"},{"issue":"4","key":"542_CR25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/ndt\/gfm785","volume":"23","author":"M Kimmel","year":"2008","unstructured":"Kimmel M, Butscheid M, Brenner S, et al. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc-preliminary results. Nephrol Dial Transplant. 2008;23(4):1241\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"542_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","volume":"32","author":"RE Katholi","year":"1998","unstructured":"Katholi RE, Woods WT, Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32:64\u201371.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"542_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0033-8389(22)01817-6","volume":"10","author":"LB Talner","year":"1972","unstructured":"Talner LB. Urographic contrast media in uremia. Physiology and pharmacology. Radiol Clin N Am. 1972;10(3):421\u201332.","journal-title":"Radiol Clin N Am"},{"issue":"17","key":"542_CR28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM197104292841701","volume":"284","author":"GH Mudge","year":"1971","unstructured":"Mudge GH. Uricosuric action of cholecystographic agents: a possible factor in nephrotoxicity. N Engl J Med. 1971;284(17):929\u201333.","journal-title":"N Engl J Med"},{"issue":"6","key":"542_CR29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-74-6-845","volume":"74","author":"AE Postlethwaite","year":"1971","unstructured":"Postlethwaite AE, Kelley WN. Uricosuric effect of radiocontrast agents: a study in man of four commonly used preparations. Ann Intern Med. 1971;74(6):845\u201352.","journal-title":"Ann Intern Med"},{"issue":"1","key":"542_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.1974.03230390048026","volume":"229","author":"HA Feldman","year":"1974","unstructured":"Feldman HA, Goldfarb S, McCurdy DK. Recurrent radiographic dye-induced acute renal failure. JAMA. 1974;229(1):72.","journal-title":"JAMA"},{"issue":"4","key":"542_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1254\/jphs.CRJ05002X","volume":"97","author":"Y Itoh","year":"2005","unstructured":"Itoh Y, Yano T, Sendo T, et al. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci. 2005;97(4):473\u201388.","journal-title":"J Pharmacol Sci."},{"issue":"41","key":"542_CR32","doi-asserted-by":"crossref","first-page":"43157","DOI":"10.1074\/jbc.M405666200","volume":"279","author":"SC Pingle","year":"2004","unstructured":"Pingle SC, Mishra S, Marcuzzi A, et al. Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. J Biol Chem. 2004;279(41):43157\u201367.","journal-title":"J Biol Chem"},{"issue":"5","key":"542_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-198611050-00001","volume":"11","author":"GA Murrell","year":"1986","unstructured":"Murrell GA, Rapeport WG. Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet. 1986;11(5):343\u201353.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"542_CR34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200746080-00001","volume":"46","author":"RO Day","year":"2007","unstructured":"Day RO, Graham GG, Hicks M, et al. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol. Clin Pharmacokinet. 2007;46(8):623\u201344.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"542_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/annrheumdis-2015-209046","volume":"76","author":"JA Singh","year":"2017","unstructured":"Singh JA, Yu S. Are allopurinol dose and duration of use nephroprotective in the elderly? A medicare claims study of allopurinol use and incident renal failure. Ann Rheum Dis. 2017;76(1):133\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"542_CR36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/qjmed\/95.9.597","volume":"95","author":"LD Fairbanks","year":"2002","unstructured":"Fairbanks LD, Cameron JS, Venkat-Raman G, et al. Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM. 2002;95(9):597\u2013607.","journal-title":"QJM"},{"issue":"3","key":"542_CR37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0100-39842008000300010","volume":"41","author":"JC Eduardo","year":"2008","unstructured":"Eduardo JC, Macedo HW, Caldas ML, et al. Contrast-induced nephropathy: evaluation of n-acetylcysteine and allopurinol protective effect in uninephrectomized rats. Radiol Bras. 2008;41(3):177\u201381.","journal-title":"Radiol Bras."},{"issue":"12","key":"542_CR38","first-page":"HC03","volume":"8","author":"A Kumar","year":"2014","unstructured":"Kumar A, Bhawani G, Kumari N, et al. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagn Res. 2014;8(12):HC03\u20137.","journal-title":"J Clin Diagn Res."},{"issue":"6","key":"542_CR39","first-page":"741","volume":"26","author":"J Almirall","year":"2005","unstructured":"Almirall J, Orellana R, Mart\u00ednez OJ, et al. Allopurinol-induced chronic granulomatous interstitial nephritis. Nefrologia. 2005;26(6):741\u20134.","journal-title":"Nefrologia."},{"issue":"2","key":"542_CR40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-86-2-196","volume":"86","author":"DR Gelbart","year":"1977","unstructured":"Gelbart DR, Weinstein AB, Fajardo LF. Allopurinol-induced interstitial nephritis. Ann Intern Med. 1977;86(2):196\u20138.","journal-title":"Ann Intern Med"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0542-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0542-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0542-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:34:05Z","timestamp":1692822845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0542-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0542-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,12]]}}}